Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension

Masaharu Kataoka, Takumi Inami, Kentaro Hayashida, Nobuhiko Shimura, Haruhisa Ishiguro, Takayuki Abe, Yuichi Tamura, Motomi Ando, Keiichi Fukuda, Hideaki Yoshino, Toru Satoh

Research output: Contribution to journalArticle

182 Citations (Scopus)

Abstract

Background-Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension. Methods and Results-Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P<0.01). Hemodynamic parameters also significantly improved (mean pulmonary arterial pressure, 45.3 ± 9.8 versus 31.8 ± 10.0 mm Hg; cardiac output, 3.6 ± 1.2 versus 4.6 ± 1.7 L/min, baseline versus follow-up, respectively; both P<0.01). Twenty-seven of 51 procedures in total (53%), and 19 of 28 first procedures (68%), had reperfusion pulmonary edema as the chief complication. Patients with severe clinical signs and/or severe hemodynamics at baseline had a high risk of reperfusion pulmonary edema. Conclusions-PTPA improved subjective symptoms and objective variables, including pulmonary hemodynamics. PTPA may be a promising therapeutic strategy for the treatment of chronic thromboembolic pulmonary hypertension.

Original languageEnglish
Pages (from-to)756-762
Number of pages7
JournalCirculation: Cardiovascular Interventions
Volume5
Issue number6
DOIs
Publication statusPublished - 2012 Dec

Fingerprint

Angioplasty
Pulmonary Hypertension
Lung
Hemodynamics
Pulmonary Edema
Therapeutics
Reperfusion
Brain Natriuretic Peptide
Cardiac Output
Arterial Pressure
Heart Failure

Keywords

  • Chronic thromboembolic pulmonary hypertension
  • Hypertension
  • Percutaneous transluminal pulmonary angioplasty
  • Pulmonary
  • Reperfusion pulmonary edema

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. / Kataoka, Masaharu; Inami, Takumi; Hayashida, Kentaro; Shimura, Nobuhiko; Ishiguro, Haruhisa; Abe, Takayuki; Tamura, Yuichi; Ando, Motomi; Fukuda, Keiichi; Yoshino, Hideaki; Satoh, Toru.

In: Circulation: Cardiovascular Interventions, Vol. 5, No. 6, 12.2012, p. 756-762.

Research output: Contribution to journalArticle

Kataoka, M, Inami, T, Hayashida, K, Shimura, N, Ishiguro, H, Abe, T, Tamura, Y, Ando, M, Fukuda, K, Yoshino, H & Satoh, T 2012, 'Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension', Circulation: Cardiovascular Interventions, vol. 5, no. 6, pp. 756-762. https://doi.org/10.1161/CIRCINTERVENTIONS.112.971390
Kataoka, Masaharu ; Inami, Takumi ; Hayashida, Kentaro ; Shimura, Nobuhiko ; Ishiguro, Haruhisa ; Abe, Takayuki ; Tamura, Yuichi ; Ando, Motomi ; Fukuda, Keiichi ; Yoshino, Hideaki ; Satoh, Toru. / Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension. In: Circulation: Cardiovascular Interventions. 2012 ; Vol. 5, No. 6. pp. 756-762.
@article{f0c0f22ecf924cbba20c37aeace77240,
title = "Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension",
abstract = "Background-Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension. Methods and Results-Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P<0.01). Hemodynamic parameters also significantly improved (mean pulmonary arterial pressure, 45.3 ± 9.8 versus 31.8 ± 10.0 mm Hg; cardiac output, 3.6 ± 1.2 versus 4.6 ± 1.7 L/min, baseline versus follow-up, respectively; both P<0.01). Twenty-seven of 51 procedures in total (53{\%}), and 19 of 28 first procedures (68{\%}), had reperfusion pulmonary edema as the chief complication. Patients with severe clinical signs and/or severe hemodynamics at baseline had a high risk of reperfusion pulmonary edema. Conclusions-PTPA improved subjective symptoms and objective variables, including pulmonary hemodynamics. PTPA may be a promising therapeutic strategy for the treatment of chronic thromboembolic pulmonary hypertension.",
keywords = "Chronic thromboembolic pulmonary hypertension, Hypertension, Percutaneous transluminal pulmonary angioplasty, Pulmonary, Reperfusion pulmonary edema",
author = "Masaharu Kataoka and Takumi Inami and Kentaro Hayashida and Nobuhiko Shimura and Haruhisa Ishiguro and Takayuki Abe and Yuichi Tamura and Motomi Ando and Keiichi Fukuda and Hideaki Yoshino and Toru Satoh",
year = "2012",
month = "12",
doi = "10.1161/CIRCINTERVENTIONS.112.971390",
language = "English",
volume = "5",
pages = "756--762",
journal = "Circulation: Cardiovascular Interventions",
issn = "1941-7640",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Percutaneous transluminal pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension

AU - Kataoka, Masaharu

AU - Inami, Takumi

AU - Hayashida, Kentaro

AU - Shimura, Nobuhiko

AU - Ishiguro, Haruhisa

AU - Abe, Takayuki

AU - Tamura, Yuichi

AU - Ando, Motomi

AU - Fukuda, Keiichi

AU - Yoshino, Hideaki

AU - Satoh, Toru

PY - 2012/12

Y1 - 2012/12

N2 - Background-Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension. Methods and Results-Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P<0.01). Hemodynamic parameters also significantly improved (mean pulmonary arterial pressure, 45.3 ± 9.8 versus 31.8 ± 10.0 mm Hg; cardiac output, 3.6 ± 1.2 versus 4.6 ± 1.7 L/min, baseline versus follow-up, respectively; both P<0.01). Twenty-seven of 51 procedures in total (53%), and 19 of 28 first procedures (68%), had reperfusion pulmonary edema as the chief complication. Patients with severe clinical signs and/or severe hemodynamics at baseline had a high risk of reperfusion pulmonary edema. Conclusions-PTPA improved subjective symptoms and objective variables, including pulmonary hemodynamics. PTPA may be a promising therapeutic strategy for the treatment of chronic thromboembolic pulmonary hypertension.

AB - Background-Chronic thromboembolic pulmonary hypertension leads to pulmonary hypertension and right-sided heart failure. The purpose of this study was to investigate the efficacy of percutaneous transluminal pulmonary angioplasty (PTPA) for the treatment of chronic thromboembolic pulmonary hypertension. Methods and Results-Twenty-nine patients with chronic thromboembolic pulmonary hypertension underwent PTPA. One patient had a wiring perforation as a complication of PTPA and died 2 days after the procedure. In the remaining 28 patients, PTPA did not produce immediate hemodynamic improvement at the time of the procedure. However, after follow-up (6.0 ± 6.9 months), New York Heart Association functional classifications and levels of plasma B-type natriuretic peptide significantly improved (both P<0.01). Hemodynamic parameters also significantly improved (mean pulmonary arterial pressure, 45.3 ± 9.8 versus 31.8 ± 10.0 mm Hg; cardiac output, 3.6 ± 1.2 versus 4.6 ± 1.7 L/min, baseline versus follow-up, respectively; both P<0.01). Twenty-seven of 51 procedures in total (53%), and 19 of 28 first procedures (68%), had reperfusion pulmonary edema as the chief complication. Patients with severe clinical signs and/or severe hemodynamics at baseline had a high risk of reperfusion pulmonary edema. Conclusions-PTPA improved subjective symptoms and objective variables, including pulmonary hemodynamics. PTPA may be a promising therapeutic strategy for the treatment of chronic thromboembolic pulmonary hypertension.

KW - Chronic thromboembolic pulmonary hypertension

KW - Hypertension

KW - Percutaneous transluminal pulmonary angioplasty

KW - Pulmonary

KW - Reperfusion pulmonary edema

UR - http://www.scopus.com/inward/record.url?scp=84873693426&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873693426&partnerID=8YFLogxK

U2 - 10.1161/CIRCINTERVENTIONS.112.971390

DO - 10.1161/CIRCINTERVENTIONS.112.971390

M3 - Article

VL - 5

SP - 756

EP - 762

JO - Circulation: Cardiovascular Interventions

JF - Circulation: Cardiovascular Interventions

SN - 1941-7640

IS - 6

ER -